Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.

Background: New World cutaneous leishmaniasis among Israeli travelers is mostly acquired in the Amazon Basin of Bolivia where Leishmania viannia (V.) braziliensis is endemic. Treatment with systemic pentavalent antimonial compounds is effective in achieving clinical cure in only 75% of cases.

Breast cancer and scleroderma.

Introduction: Epidemiologic studies have shown that patients with scleroderma have an increased risk of cancer.

Methods: The authors report eight cases and retrospectively review the published data on the possible association between breast cancer and scleroderma of the cutaneous and systemic forms. The records of all patients with scleroderma and breast cancer who were hospitalized during 1980-2002 in the Chaim Sheba Medical Center were surveyed.

Recurrent erysipelas: risk factors.

Background: Several systemic and regional risk factors have been described for erysipelas. However, those predisposing for recurrent episodes are not well defined.

Materials And Methods: We performed a retrospective analysis of 574 patients hospitalized in our institution during a 3 year period.

Experience with New World cutaneous leishmaniasis in travelers.

In recent years, New World cutaneous leishmaniasis has been seen at a higher incidence among returning Israeli travelers. Leishmania braziliensis and related species cause unsightly cutaneous lesions possibly complicated with a mucosal disease. A total of 12 patients with New World cutaneous leishmaniasis were treated in our clinic, 11 of whom (92%) acquired the disease in the Bolivian Amazon Basin.